Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, to reduce the risk of non-fatal myocardial ...

The success of GLP-1R-targeting drugs highlights their viability as a treatment approach. Currently, there are four ...

Health Canada has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

A drug used to help Canadians lose weight has now been approved to reduce the risk of non-fatal heart attacks. Novo Nordisk ...

But for a long time China’s people struggled to get hold of Wegovy because the country’s regulators had not approved it. Some ...

The annual meeting of the American Heart Association was held this year from Nov. 16 to 18 in Chicago, drawing attendees from around the world, includ ...

$ 105.13 0.07 0.07% ...

Manipur violence: 94 checkpoints installed, search operations on in Jiribam Manipur Police intensified security measures, establishing 94 checkpoints and conducting searches following recent ...